MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.



A survey of TB diagnostic and treatment practices in eight countries, October 2014.

MSF briefing paper, December 2014

What began in 2011 in Syria as protests inspired by the Arab Spring has become an entrenched and bloody conflict that shows no sign of resolution. Today, with an estimated 200,000 people killed and 7.6 million people displaced within the country and 3.2 million refugees registered outside, Syria is seen as the world’s most grave humanitarian disaster. In the face of this crisis, the previously functioning health system has collapsed and scores of thousands of medical staff have fled.

Iraq experienced a dramatic surge in violence in 2014 that triggered successive large-scale waves of displacement. More than 2.6 million people are said to have fled war-torn the central and northern areas of Iraq, particularly Al-Anbar, Ninawa, Salah Al-Din, Kirkuk and Diyala governorates.

September 29, 2015

On September 28, Doctors Without Borders/Médecins Sans Frontières' (MSF) took advantage of Indian Prime Minister Narendra Modi being in New York City to send him a message. Thanks to the country's patent laws, India is the pharmacy to the developing world; MSF sources 80% of its HIV drugs from India among other essential medicines. The U.S. is pressuring PM Modi to make India's patent laws more restrictive, which would benefit big pharma companies and cause millions of people to lose access to affordable medicines. MSF is urging PM Modi not to give in to U.S. pressure.

September 28, 2015

NEW YORK—As US president Barack Obama and Indian prime minister Narendra Modi meet in New York today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that US pressure on India to change its intellectual property policies could result in millions of people around the world losing their lifeline of affordable medicines.

July 21, 2015

MSF wants Indian Prime Minister Modi to reject any external proposal that undermines the production of affordable generic medicines in India, the "pharmacy of developing world."

June 12, 2015

New Delhi/GenevaThe international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched a global campaign urging Indian Prime Minister Narendra Modi to stand strong in the face of intensifying multinational pressure to change India’s laws and policies that would severely restrict production of affordable medicines, upon which millions of people around the world depend.

April 07, 2015

MSF published evidence from its community-based management of acute malnutrition program in Bihar, India, which revealed that it has successfully achieved a cure rate of 88.4 percent among severely acute malnourished children who completed treatment.

January 26, 2015

Secret meeting this week in New York a chance to remove provisions that threaten access to lifesaving medicines.

January 23, 2015

New intellectual property "think tank" draft policy already showing alarming trend.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.